Why did ABT.SW stock spike in volume on Jan 23 2026?

Volume spiked after Abbott’s earnings commentary and headlines about weaker baby-formula sales. Traders reacted to the guidance detail and diagnostics strength, producing a relative volume of **40.00** versus average **1.00** on the SIX session.

What are the key valuation metrics for ABT.SW?

Key metrics: **Price CHF100.00**, **EPS 6.37**, **PE 15.70**, price-to-sales **5.02**, price-to-book **4.35**, dividend yield **1.94%**. These support a stable valuation with moderate yield.

What price targets does Meyka AI project for ABT.SW stock?

Meyka AI's forecast model projects monthly **CHF98.19**, quarterly **CHF110.78**, and yearly **CHF91.69**. The quarterly target implies **+10.78%** from CHF100.00. Forecasts are projections, not guarantees.

How should traders use the volume spike signal?

Use the spike to reassess risk and liquidity. Watch **CHF102.26** (200-day MA) and **CHF99.24** (50-day MA). A sustained move above the 200-day MA supports momentum; failure to hold CHF100.00 suggests short-term downside.

CH Stocks

Volume spike: ABT.SW Abbott (SIX) Jan 23 2026 Market closed, watch formula sales

ByHuzaifa Zahoor January 24, 2026January 24, 2026

The ABT.SW stock jumped on a clear volume spike as Swiss trading closed on 23 Jan 2026. Abbott (ABT.SW) ended at CHF100.00, up CHF1.00 or 1.01%, on volume 40.00 shares versus an average of 1.00. The surge followed mixed earnings commentary and headlines about weaker baby-formula sales, while diagnostics demand showed resilience. With a relative volume of 40.00, this move signals elevated trader attention in the SIX Switzerland session and sets the tone for short-term positioning.